Daniel Ives: Strongly Encourage Investors to Stay the Course on Apple
For more on Daniel Ives’ comments: 5 Top Stocks to Buy on Trade War Weakness
Peter Winter: Potential Risk Brewing To The Multi-Family Lending Business In New York
For more on Peter Winter’s comments: NYC-Exposed Banks Fall as Wedbush Warns of Threat From Democrats
David Nierengarten: Impressively Broad Pipeline Are Sources Of Future Value
For more on David Nierengarten’s comments: Bluebird Bio’s Pricing Plan Worries One Biotech Analyst. Here’s Why.
Daniel Ives: Financial Services They Provide Diversify Revenue Streams
For more on Daniel Ives’ comments: Uber’s IPO flop bodes ill for Grab and Go-Jek
David Nierengarten: We See Risks To The ZYNTEGLO (LentiGlobin) Launch
For more on David Nierengarten’s comments: Traders Get Temporary Lyft But Need an Uber Rally: Taking Stock